To direct the Federal Trade Commission to conduct an investigation and submit to Congress a report on unfair or deceptive acts or practices that may be prevalent in the advertising or marketing of preterm infant formula and to issue regulations to prohibit unfair or deceptive acts or practices related to the advertising or marketing of preterm infant formula, and for other purposes.
About This Bill
Committee
Latest Action · July 27, 2026
Referred to the House Committee on Energy and Commerce.
H.R. 9969, called Baby Brent's Bill, directs the Federal Trade Commission to investigate and regulate advertising and marketing practices for preterm infant formula. The bill requires the FTC to examine whether manufacturers are using unfair or deceptive advertising, particularly regarding health risks and differences between human milk-based fortifiers and bovine-based fortifiers, with the investigation to be completed within one year of enactment. The FTC must then issue regulations prohibiting deceptive advertising practices within eighteen months of submitting its report, with enforcement handled through existing FTC authority. The bill reflects congressional concern that one baby dies daily from necrotizing enterocolitis, a serious gastrointestinal condition affecting premature infants, and aims to ensure parents receive full information about infant feeding options and that families can pursue legal compensation if their preterm infants are harmed. The legislation affects manufacturers and importers of preterm infant formula, which includes any formula designed for infants born before 37 weeks of gestation or with low birth weight.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.